These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2341732)
1. Soft tissue abscess caused by Mycobacterium fortuitum. Westmoreland D; Woodwards RT; Holden PE; James PA J Infect; 1990 May; 20(3):223-5. PubMed ID: 2341732 [TBL] [Abstract][Full Text] [Related]
2. Subcutaneous abscess caused by Mycobacterium conceptionense in an immunocompetent patient. Liao CH; Lai CC; Huang YT; Chou CH; Hsu HL; Hsueh PR J Infect; 2009 Apr; 58(4):308-9. PubMed ID: 19286264 [No Abstract] [Full Text] [Related]
3. Cefoxitin therapy for Mycobacterium fortuitum bacteremia with associated granulomatous hepatitis. Brannan DP; DuBois RE; Ramirez MJ; Ravry MJ; Harrison EO South Med J; 1984 Mar; 77(3):381-4. PubMed ID: 6422563 [TBL] [Abstract][Full Text] [Related]
4. Mycobacterium chelonei and abscess formation in soft tissues. Hanson PJ; Thomas JM; Collins JV Tubercle; 1987 Dec; 68(4):297-9. PubMed ID: 3455569 [TBL] [Abstract][Full Text] [Related]
5. Mycobacterium fortuitum as a cause for nasolacrimal obstruction and granulomatous eyelid disease. Katowitz JA; Kropp TM Ophthalmic Surg; 1987 Feb; 18(2):97-9. PubMed ID: 3574874 [TBL] [Abstract][Full Text] [Related]
6. Mycobacterium chelonei facial abscess: case presentation and review of cutaneous infection due to Runyon Group IV organisms. Hamrick HJ; Maddux DW; Lowry EK; Taylor LL; Henderson FW; Pillsbury HC Pediatr Infect Dis; 1984; 3(4):335-40. PubMed ID: 6473138 [No Abstract] [Full Text] [Related]
7. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. Wallace RJ; Swenson JM; Silcox VA; Bullen MG J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667 [TBL] [Abstract][Full Text] [Related]
8. Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note. Plemmons RM; McAllister CK; Liening DA; Garces MC Clin Infect Dis; 1996 Jun; 22(6):1105-6. PubMed ID: 8783722 [TBL] [Abstract][Full Text] [Related]
9. Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice. Saito H; Sato K; Jin BW Antimicrob Agents Chemother; 1984 Aug; 26(2):270-1. PubMed ID: 6592999 [TBL] [Abstract][Full Text] [Related]
10. Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum. Kunin M; Salamon F; Weinberger M; Genkin I; Sagie A; Tur-Kaspa R Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):539-41. PubMed ID: 12172746 [TBL] [Abstract][Full Text] [Related]